2. Academic Validation
  3. KT5823 activates human neutrophils and fails to inhibit cGMP-dependent protein kinase phosphorylation of vimentin

KT5823 activates human neutrophils and fails to inhibit cGMP-dependent protein kinase phosphorylation of vimentin

  • Res Commun Chem Pathol Pharmacol. 1991 Oct;74(1):3-14.
T A Wyatt 1,  K B Pryzwansky,  T M Lincoln
Affiliations

Affiliation

  • 1 Department of Pathology, University of North Carolina, Chapel Hill 27599-7525.
PMID: 1666198
Abstract

The effectiveness of the cGMP-dependent protein kinase inhibitor, KT5823, was investigated in human neutrophils. KT5823 did not inhibit the cGMP-dependent protein kinase mediated in vitro, or in situ phosphorylation of vimentin, a known substrate for this Enzyme in activated neutrophils. In addition, KT5823 was shown to induce dramatic shape changes in neutrophils, suggesting it has an activating effect upon the cells.

Figures
Products